{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:20:44Z","timestamp":1790248844070,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.hoc.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T01:41:55Z","timestamp":1504921315000},"page":"753-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Nonintegrating Gene Therapy Vectors"],"prefix":"10.1016","volume":"31","author":[{"given":"Takis","family":"Athanasopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Munye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael J.","family":"Y\u00e1\u00f1ez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5155","key":"10.1016\/j.hoc.2017.06.007_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/219749a0","article-title":"Use of viruses as carriers of added genetic information","volume":"219","author":"Rogers","year":"1968","journal-title":"Nature"},{"issue":"4025","key":"10.1016\/j.hoc.2017.06.007_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.175.4025.949","article-title":"Gene therapy for human genetic disease?","volume":"175","author":"Friedmann","year":"1972","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.hoc.2017.06.007_bib3","first-page":"1","article-title":"Unsuccessful trial of gene replacement in arginase deficiency","volume":"119","author":"Terheggen","year":"1975","journal-title":"Z\u00a0Kinderheilkd"},{"issue":"5235","key":"10.1016\/j.hoc.2017.06.007_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T\u00a0lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"issue":"5466","key":"10.1016\/j.hoc.2017.06.007_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.hoc.2017.06.007_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"Heise","year":"1997","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.hoc.2017.06.007_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","article-title":"Clinical trials with oncolytic adenovirus in China","volume":"7","author":"Yu","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.hoc.2017.06.007_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd3572-c1","article-title":"Glybera and the future of gene therapy in the European Union","volume":"11","author":"Miller","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.hoc.2017.06.007_bib9","doi-asserted-by":"crossref","first-page":"e1115641","DOI":"10.1080\/2162402X.2015.1115641","article-title":"First oncolytic virus approved for melanoma immunotherapy","volume":"5","author":"Pol","year":"2016","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.hoc.2017.06.007_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/hum.2015.095","article-title":"Recent advancements in cardiovascular gene therapy and vascular biology","volume":"26","author":"Laakkonen","year":"2015","journal-title":"Hum Gene Ther"},{"issue":"6","key":"10.1016\/j.hoc.2017.06.007_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01904-16","article-title":"Adenovirus Modulates Toll-Like Receptor 4 Signaling by Reprogramming ORP1L-VAP Protein Contacts for Cholesterol Transport from Endosomes to the Endoplasmic Reticulum","volume":"91","author":"Cianciola","year":"2017","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.hoc.2017.06.007_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/mthe.2001.0305","article-title":"A\u00a0death in the laboratory: the politics of the Gelsinger aftermath","volume":"3","author":"Carmen","year":"2001","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.hoc.2017.06.007_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/156652321305131212125338","article-title":"Helper dependent adenovirus vectors: progress and future prospects","volume":"13","author":"Cots","year":"2013","journal-title":"Curr Gene Ther"},{"issue":"9","key":"10.1016\/j.hoc.2017.06.007_bib14","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/sj.gt.3300995","article-title":"Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration","volume":"6","author":"Parks","year":"1999","journal-title":"Gene Ther"},{"issue":"6","key":"10.1016\/j.hoc.2017.06.007_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/hum.2014.123","article-title":"A\u00a0hybrid adenoviral vector system achieves efficient long-term gene expression in the Liver via piggyBac Transposition","volume":"26","author":"Smith","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.hoc.2017.06.007_bib16","doi-asserted-by":"crossref","first-page":"10225","DOI":"10.1038\/srep10225","article-title":"Targeting blood thrombogenicity precipitates atherothrombotic events in a mouse model of plaque destabilization","volume":"5","author":"Liu","year":"2015","journal-title":"Scientific Rep"},{"key":"10.1016\/j.hoc.2017.06.007_bib17","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1038\/mtm.2014.57","article-title":"Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5\/35 vectors expressing site-specific endonucleases under microRNA regulation","volume":"1","author":"Saydaminova","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"46","key":"10.1016\/j.hoc.2017.06.007_bib18","doi-asserted-by":"crossref","first-page":"27487","DOI":"10.1074\/jbc.M115.669960","article-title":"Structural Insights into the Assembly of the Adeno-associated Virus Type 2 Rep68 Protein on the Integration Site AAVS1","volume":"290","author":"Musayev","year":"2015","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.hoc.2017.06.007_bib19","doi-asserted-by":"crossref","first-page":"e1000985","DOI":"10.1371\/journal.ppat.1000985","article-title":"Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome","volume":"6","author":"Huser","year":"2010","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.hoc.2017.06.007_bib20","first-page":"363","article-title":"Gene therapy vectors based on adeno-associated virus: characteristics and applications to acquired and inherited diseases (review)","volume":"6","author":"Athanasopoulos","year":"2000","journal-title":"Int J Mol Med"},{"issue":"7","key":"10.1016\/j.hoc.2017.06.007_bib21","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1093\/ndt\/gfp019","article-title":"Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis","volume":"24","author":"Wilde","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.hoc.2017.06.007_bib22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","article-title":"In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector","volume":"12","author":"Zinn","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.hoc.2017.06.007_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","article-title":"In\u00a0vivo tissue-tropism of adeno-associated viral vectors","volume":"21","author":"Srivastava","year":"2016","journal-title":"Curr Opin Virol"},{"issue":"7","key":"10.1016\/j.hoc.2017.06.007_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat Rev Genet"},{"issue":"7588","key":"10.1016\/j.hoc.2017.06.007_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature16465","article-title":"An essential receptor for adeno-associated virus infection","volume":"530","author":"Pillay","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.hoc.2017.06.007_bib26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/mt.2014.107","article-title":"Gene transfer properties and structural modeling of human stem cell-derived AAV","volume":"22","author":"Smith","year":"2014","journal-title":"Mol Ther"},{"issue":"25","key":"10.1016\/j.hoc.2017.06.007_bib27","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.hoc.2017.06.007_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/hae.12411","article-title":"Current status of haemophilia gene therapy","volume":"20","author":"High","year":"2014","journal-title":"Haemophilia"},{"issue":"10","key":"10.1016\/j.hoc.2017.06.007_bib29","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2014-07-588194","article-title":"AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice","volume":"125","author":"Crudele","year":"2015","journal-title":"Blood"},{"issue":"S3","key":"10.1016\/j.hoc.2017.06.007_bib30","first-page":"15","article-title":"Initiation of Oral Steroid Therapy Produced Rapid Normalization of Transaminase Levels and Stabilization of FIX Activity in Subjects Who Developed T-Cell Responses in the SPK-9001: AAV Gene Transfer for Hemophilia B Phase 1\/2 Trial","volume":"23","author":"George","year":"2017","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.hoc.2017.06.007_bib31","doi-asserted-by":"crossref","first-page":"e0151800","DOI":"10.1371\/journal.pone.0151800","article-title":"Successful phenotype improvement following gene therapy for severe hemophilia a in privately owned dogs","volume":"11","author":"Callan","year":"2016","journal-title":"PLoS One"},{"issue":"S4","key":"10.1016\/j.hoc.2017.06.007_bib32","first-page":"151","article-title":"Interim results of an open-label, phase 1\/2 study of BMN 270, an AAV5-FVIII gene transfer in severe hemophilia A","volume":"22","author":"Pasi","year":"2016","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.hoc.2017.06.007_bib33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2011-09-377630","article-title":"AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage","volume":"119","author":"Binny","year":"2012","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.hoc.2017.06.007_bib34","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2013-02-486779","article-title":"AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura","volume":"121","author":"Jin","year":"2013","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.hoc.2017.06.007_bib35","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2014-12-615492","article-title":"In\u00a0vivo genome editing of the albumin locus as a platform for protein replacement therapy","volume":"126","author":"Sharma","year":"2015","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2017.06.007_bib36","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/jgm.501","article-title":"Lentiviral vectors: optimization of packaging, transduction and gene expression","volume":"6","author":"Delenda","year":"2004","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.hoc.2017.06.007_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In\u00a0vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.hoc.2017.06.007_bib38","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.gt.3301023","article-title":"Stable gene transfer to the nervous system using a non-primate lentiviral vector","volume":"6","author":"Mitrophanous","year":"1999","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.hoc.2017.06.007_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/1521-2254(200009\/10)2:5<308::AID-JGM131>3.0.CO;2-3","article-title":"Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy","volume":"2","author":"Vigna","year":"2000","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.hoc.2017.06.007_bib40","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in\u00a0vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.hoc.2017.06.007_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A\u00a0serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2017.06.007_bib42","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.hoc.2017.06.007_bib43","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/mt.2009.122","article-title":"Integration-deficient lentiviral vectors: a slow coming of age","volume":"17","author":"Wanisch","year":"2009","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.hoc.2017.06.007_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/gt.2012.78","article-title":"Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord","volume":"20","author":"Peluffo","year":"2013","journal-title":"Gene Ther"},{"issue":"47","key":"10.1016\/j.hoc.2017.06.007_bib45","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.1073\/pnas.0606197103","article-title":"Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in\u00a0vitro and in\u00a0vivo","volume":"103","author":"Philippe","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.hoc.2017.06.007_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1365","article-title":"Effective gene therapy with nonintegrating lentiviral vectors","volume":"12","author":"Y\u00e1\u00f1ez-Mu\u00f1oz","year":"2006","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.hoc.2017.06.007_bib47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/hum.2014.003","article-title":"Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's Disease","volume":"25","author":"Lu-Nguyen","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.hoc.2017.06.007_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.molcel.2004.09.023","article-title":"Retroviral pseudotransduction for targeted cell manipulation","volume":"16","author":"Galla","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.hoc.2017.06.007_bib49","doi-asserted-by":"crossref","first-page":"e01911","DOI":"10.7554\/eLife.01911","article-title":"Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases","volume":"3","author":"Cai","year":"2014","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.hoc.2017.06.007_bib50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ymthe.2006.01.008","article-title":"Transient gene expression by nonintegrating lentiviral vectors","volume":"13","author":"Nightingale","year":"2006","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/j.hoc.2017.06.007_bib51","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/mt.2013.106","article-title":"Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus","volume":"21","author":"Joglekar","year":"2013","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.hoc.2017.06.007_bib52","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/mt.2009.10","article-title":"Hybrid lentivirus-transposon vectors with a random integration profile in human cells","volume":"17","author":"Staunstrup","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.hoc.2017.06.007_bib53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1472-6750-8-60","article-title":"Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase","volume":"8","author":"Moldt","year":"2008","journal-title":"BMC Biotechnol"},{"issue":"4","key":"10.1016\/j.hoc.2017.06.007_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/gt.2014.1","article-title":"An integration-defective lentivirus-based resource for site-specific targeting of an edited safe-harbour locus in the human genome","volume":"21","author":"Torres","year":"2014","journal-title":"Gene Ther"},{"issue":"34","key":"10.1016\/j.hoc.2017.06.007_bib55","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1016\/j.vaccine.2012.05.063","article-title":"Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in\u00a0vitro and in\u00a0vivo","volume":"30","author":"Daenthanasanmak","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.hoc.2017.06.007_bib56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/mt.2013.278","article-title":"Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells","volume":"22","author":"Tareen","year":"2014","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.hoc.2017.06.007_bib57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/104303404322959515","article-title":"Novel integrase-defective lentiviral episomal vectors for gene transfer","volume":"15","author":"Vargas","year":"2004","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.hoc.2017.06.007_bib58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.antiviral.2008.06.015","article-title":"Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy","volume":"80","author":"Vargas","year":"2008","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.hoc.2017.06.007_bib59","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/hum.2013.172","article-title":"Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors","volume":"25","author":"Kym\u00e4l\u00e4inen","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"6","key":"10.1016\/j.hoc.2017.06.007_bib60","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/1566523034578168","article-title":"The uses of poxviruses as vectors","volume":"3","author":"Vanderplasschen","year":"2003","journal-title":"Curr Gene Ther"},{"issue":"4","key":"10.1016\/j.hoc.2017.06.007_bib61","first-page":"317","article-title":"Gene therapy with poxvirus vectors","volume":"7","author":"Moroziewicz","year":"2005","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.hoc.2017.06.007_bib62","series-title":"Fields virology","first-page":"2129","article-title":"Poxviridae","author":"Moss","year":"2013"},{"issue":"1","key":"10.1016\/j.hoc.2017.06.007_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-1119(83)90163-4","article-title":"Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA","volume":"25","author":"Smith","year":"1983","journal-title":"Gene"},{"key":"10.1016\/j.hoc.2017.06.007_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development","volume":"97","author":"Volz","year":"2017","journal-title":"Adv Virus Res"},{"issue":"1","key":"10.1016\/j.hoc.2017.06.007_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JVI.01894-15","article-title":"Natural killer cells and innate interferon gamma participate in the host defense against respiratory vaccinia virus infection","volume":"90","author":"Abboud","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.hoc.2017.06.007_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fimmu.2013.00007","article-title":"NK cells and poxvirus infection","volume":"4","author":"Burshtyn","year":"2013","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.hoc.2017.06.007_bib67","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4161\/hv.21080","article-title":"A\u00a0vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication","volume":"8","author":"Verardi","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.hoc.2017.06.007_bib68","first-page":"415","article-title":"Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease","volume":"7","author":"Latchman","year":"2005","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.hoc.2017.06.007_bib69","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/mtm.2016.57","article-title":"Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR\/Cas9 for efficient gene editing","volume":"3","author":"Park","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"34","key":"10.1016\/j.hoc.2017.06.007_bib70","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1073\/pnas.1103509108","article-title":"Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors","volume":"108","author":"Ban","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.hoc.2017.06.007_bib71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/nar\/5.2.563","article-title":"Insertion of synthetic copies of human globin genes into bacterial plasmids","volume":"5","author":"Wilson","year":"1978","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.hoc.2017.06.007_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0092-8674(83)90216-7","article-title":"Transcriptional activation of cloned human beta-globin genes by viral immediate-early gene products","volume":"35","author":"Green","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.hoc.2017.06.007_bib73","doi-asserted-by":"crossref","first-page":"23125","DOI":"10.1038\/srep23125","article-title":"Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer","volume":"6","author":"Munye","year":"2016","journal-title":"Scientific Rep"},{"issue":"5","key":"10.1016\/j.hoc.2017.06.007_bib74","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/mt.2013.33","article-title":"A\u00a0mini-intronic plasmid (MIP): a novel robust transgene expression vector in\u00a0vivo and in\u00a0vitro","volume":"21","author":"Lu","year":"2013","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.hoc.2017.06.007_bib75","doi-asserted-by":"crossref","first-page":"e69879","DOI":"10.1371\/journal.pone.0069879","article-title":"Production and characterization of novel recombinant adeno-associated virus replicative-form genomes: a eukaryotic source of DNA for gene transfer","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.hoc.2017.06.007_bib76","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.hoc.2017.06.007_bib77","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1073\/pnas.86.5.1598","article-title":"Yeast artificial chromosomes with 200- to 800-kilobase inserts of human DNA containing HLA, V kappa, 5S, and Xq24-Xq28 sequences","volume":"86","author":"Little","year":"1989","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.1016\/j.hoc.2017.06.007_bib78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10577-014-9460-6","article-title":"Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes","volume":"23","author":"Tedesco","year":"2015","journal-title":"Chromosome Res"},{"issue":"5","key":"10.1016\/j.hoc.2017.06.007_bib79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molmed.2005.03.006","article-title":"Artificial and engineered chromosomes: non-integrating vectors for gene therapy","volume":"11","author":"Basu","year":"2005","journal-title":"Trends Mol Med"},{"issue":"23","key":"10.1016\/j.hoc.2017.06.007_bib80","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.84.23.8463","article-title":"Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading","volume":"84","author":"Fechheimer","year":"1987","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"7","key":"10.1016\/j.hoc.2017.06.007_bib81","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","article-title":"Gene transfer into mouse lyoma cells by electroporation in high electric fields","volume":"1","author":"Neumann","year":"1982","journal-title":"EMBO J"},{"issue":"2 Pt 2","key":"10.1016\/j.hoc.2017.06.007_bib82","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0092-8674(80)90358-X","article-title":"High efficiency transformation by direct microinjection of DNA into cultured mammalian cells","volume":"22","author":"Capecchi","year":"1980","journal-title":"Cell"},{"issue":"6117","key":"10.1016\/j.hoc.2017.06.007_bib83","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/327070a0","article-title":"High-velocity microprojectiles for delivering nucleic acids into living cells","volume":"327","author":"Klein","year":"1987","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.hoc.2017.06.007_bib84","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.gt.3300572","article-title":"The efficient expression of intravascularly delivered DNA in rat muscle","volume":"5","author":"Budker","year":"1998","journal-title":"Gene Ther"},{"issue":"21","key":"10.1016\/j.hoc.2017.06.007_bib85","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1016\/S0021-9258(19)70482-7","article-title":"Introduction of liposome-encapsulated SV40 DNA into cells","volume":"255","author":"Fraley","year":"1980","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.hoc.2017.06.007_bib86","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/bi952436a","article-title":"Potentiation of cationic liposome-mediated gene delivery by polycations","volume":"35","author":"Gao","year":"1996","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.hoc.2017.06.007_bib87","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/leu.2016.180","article-title":"Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors","volume":"31","author":"Monjezi","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2017.06.007_bib88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jim.2015.04.007","article-title":"A\u00a0procedure for efficient non-viral siRNA transfection of primary human monocytes using nucleofection","volume":"422","author":"Scherer","year":"2015","journal-title":"J\u00a0Immunol Methods"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858817301004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858817301004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:04:46Z","timestamp":1760184286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858817301004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0889858817301004"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2017.06.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonintegrating Gene Therapy Vectors","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}